The possible increased risk of CRC in this population is consistent with the occurrence of early-onset CRC in 2 of the 3 CDH1 PV carriers diagnosed and the detection of advanced adenomas/SSLs in the age group below 45 years. This evidence concerns the gene CDH1 and adenoma.